The American Journal of Managed Care

LAMA-LABA Therapy Provides Improved Outcomes in COPD Over ICS-LABA

The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
Medscape

LAMA and LABA in Patients with COPD Show Similar Risk of Cardiovascular Events

LAMAs were found to be safe and effective in the treatment of COPD and have been recommended by international clinical guidelines for the management of symptoms in COPD. A population-based cohort ...
Medical Xpress

LAMA plus LABA tied to fewer exacerbations in stable COPD

(HealthDay)—Treatment with long-acting muscarinic antagonists (LAMA) plus long-acting β-agonists (LABA) is associated with fewer exacerbation events in patients with chronic obstructive pulmonary ...
Healio

LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization

Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...
Business Wire

Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting

INDIANAPOLIS & RIDGEFIELD, Conn.--(BUSINESS WIRE)--The first patients have now enrolled in AIRWISE, the world’s largest ever pragmatic clinical trial in chronic obstructive pulmonary disease (COPD) to ...
The American Journal of Managed Care

Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen

Inhaled corticosteroids (ICSs) are a key incorporation to COPD treatment strategies. Jeffrey D. Dunn, PharmD, MBA: ICSs [inhaled corticosteroids] haven’t shown much evidence in impacting the course of ...
MedPage Today

Triple Therapy for COPD: One Drug Too Many, Too Often?

SAN FRANCISCO -- Patients with chronic obstructive pulmonary disease (COPD) who changed treatment from so-called triple therapy to a two-drug product omitting the inhaled corticosteroid (ICS) ...
clinicaladvisor.com

Strategies for Preventing COPD Exacerbations in Primary Care Settings

Credit: Scott Bodell/MedicalImages.com The authors outline preventative pharmacologic therapies for COPD exacerbations and a patient-tailored approach to management. Chronic obstructive pulmonary ...
EurekAlert!

LAMA combination therapy more effective for COPD patients with exercise intolerance

April 14, 2020--Clinicians grappling with the pharmacologic management of COPD in patients complaining of exercise intolerance or dyspnea now have new guidance. The American Thoracic Society has ...
clinicaladvisor.com

GOLD Report includes updated COPD management recommendations

GOLD Report 2017 includes revised definition of COPD The GOLD Report includes a revised definition of COPD and updates guidelines for managing exacerbations. The 2017 Global Initiative for Chronic ...
Seeking Alpha

How Will GlaxoSmithKline's Triple Therapy Combination Perform In The Market?

GSK expects that it respiratory sales in 2020 will be at atleast at the same levels as in 2015. Advair generic competition will knock off almost 50% of GSK's respiratory business by 2020. The much ...